IBDEI1H6 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23862,1,3,0)
 ;;=3^Heart Failure,End Stage
 ;;^UTILITY(U,$J,358.3,23862,1,4,0)
 ;;=4^I50.84
 ;;^UTILITY(U,$J,358.3,23862,2)
 ;;=^5151391
 ;;^UTILITY(U,$J,358.3,23863,0)
 ;;=I50.89^^82^1033^11
 ;;^UTILITY(U,$J,358.3,23863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23863,1,3,0)
 ;;=3^Heart Failure,Other
 ;;^UTILITY(U,$J,358.3,23863,1,4,0)
 ;;=4^I50.89
 ;;^UTILITY(U,$J,358.3,23863,2)
 ;;=^5151392
 ;;^UTILITY(U,$J,358.3,23864,0)
 ;;=E03.9^^82^1034^21
 ;;^UTILITY(U,$J,358.3,23864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23864,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,23864,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,23864,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,23865,0)
 ;;=E11.9^^82^1034^13
 ;;^UTILITY(U,$J,358.3,23865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23865,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,23865,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,23865,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,23866,0)
 ;;=E10.9^^82^1034^7
 ;;^UTILITY(U,$J,358.3,23866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23866,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,23866,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,23866,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,23867,0)
 ;;=E11.65^^82^1034^9
 ;;^UTILITY(U,$J,358.3,23867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23867,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,23867,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,23867,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,23868,0)
 ;;=E10.65^^82^1034^5
 ;;^UTILITY(U,$J,358.3,23868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23868,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,23868,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,23868,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,23869,0)
 ;;=E11.8^^82^1034^8
 ;;^UTILITY(U,$J,358.3,23869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23869,1,3,0)
 ;;=3^DM Type 2 w/ Complications,Unspec
 ;;^UTILITY(U,$J,358.3,23869,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,23869,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,23870,0)
 ;;=E10.8^^82^1034^4
 ;;^UTILITY(U,$J,358.3,23870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23870,1,3,0)
 ;;=3^DM Type 1 w/ Complications,Unspec
 ;;^UTILITY(U,$J,358.3,23870,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,23870,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,23871,0)
 ;;=E53.8^^82^1034^31
 ;;^UTILITY(U,$J,358.3,23871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23871,1,3,0)
 ;;=3^Vitamin B Group Deficiency
 ;;^UTILITY(U,$J,358.3,23871,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,23871,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,23872,0)
 ;;=E78.5^^82^1034^20
 ;;^UTILITY(U,$J,358.3,23872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23872,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,23872,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,23872,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,23873,0)
 ;;=E66.9^^82^1034^28
 ;;^UTILITY(U,$J,358.3,23873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23873,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,23873,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,23873,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,23874,0)
 ;;=E66.01^^82^1034^26
 ;;^UTILITY(U,$J,358.3,23874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23874,1,3,0)
 ;;=3^Morbid Obesity d/t Excess Calories
 ;;^UTILITY(U,$J,358.3,23874,1,4,0)
 ;;=4^E66.01
